Skip to main content

Muscular Dystrophy News

Related terms: Myotonic Muscular Dystrophy, Myotonic Dystrophy, Dystrophia Myotonica, Steinert's Disease, Becker Muscular Dystrophy, MD, Emery-Dreifuss Muscular Dystrophy, Facioscapulohumeral Muscular Dystrophy

In Early Research, Heart Drugs Show Promise in Fighting Muscular Dystrophy

WEDNESDAY, Jan. 3, 2024 – A regularly prescribed class of heart medications might be capable of treating one of the most common forms of muscular dystrophy, a new study in mice suggests. Myotonic...

FDA Approves Vyondys 53 (golodirsen) Injection for the Treatment of Duchenne Muscular Dystrophy (DMD) in Patients Amenable to Skipping Exon 53

CAMBRIDGE, Mass., Dec. 12, 2019 (GLOBE NEWSWIRE) – Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that the U.S. Food and Drug...

FDA Approves Emflaza (deflazacort) to treat Duchenne Muscular Dystrophy

February 9, 2017 – The U.S. Food and Drug Administration today approved Emflaza (deflazacort) tablets and oral suspension to treat patients age 5 years and older with Duchenne muscular dystrophy...

FDA Approves Exondys 51 (eteplirsen) for Duchenne Muscular Dystrophy

September 19, 2016 – The U.S. Food and Drug Administration today approved Exondys 51 (eteplirsen) injection, the first drug approved to treat patients with Duchenne muscular dystrophy (DMD). Exondys...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Spinal Muscular Atrophy, Duchenne Muscular Dystrophy